Mother Cells Treatment: Real Results Doctors Confirmed
Mother cells treatment — also called stem cell therapy — is FDA-approved for blood cancers and immune disorders. 2026 guide with real costs, side effects, and doctor-verified results.
Dr. Omar Hassan, MD (Internal Medicine)
Board Certifications: Internal Medicine (1995); Geriatric Medicine (2000); Hospital Medicine (2008)
Experience: 30 years | Location: Dubai, UAE
Education: MBBS, Cairo University Faculty of Medicine (1992); MD Internal Medicine, Ain Shams University (1995); Advanced Training in Hospital Medicine, Cleveland Clinic (2007)
Dr. Omar Hassan is a highly distinguished internist with an exceptional 30-year career managing complex chronic diseases and training generations of physicians across the Middle East. As one of Dubai's most respected senior physicians, Dr. Hassan has treated over 35,000 patients and serves as a mentor and clinical educator to hundreds of medical professionals.
After completing his MD in Internal Medicine with academic distinction in Egypt, Dr. Hassan moved to the Gulf region where he pioneered comprehensive chronic disease management programs integrating evidence-based protocols with patient education and lifestyle modification. His systematic approach to hypertension management—combining medication optimization, dietary counseling, and stress reduction—has consistently achieved blood pressure control rates exceeding 85%, well above international benchmarks.
Dr. Hassan specializes in managing medically complex patients with multiple comorbidities, a population increasingly common in modern medicine. His expertise spans diabetes, cardiovascular disease, chronic kidney disease, COPD, and polypharmacy management in elderly patients. He has developed clinical pathways for hospitalists managing acute decompensations of chronic illnesses, reducing hospital readmission rates and improving patient outcomes.
As a prolific medical educator, Dr. Hassan has authored multiple continuing medical education (CME) guides on topics including hypertension management, heart failure treatment, diabetes complications, and anticoagulation therapy. His CME courses have been completed by over 5,000 physicians across the Middle East and North Africa region. He regularly lectures at Dubai Medical College and serves as an examiner for the Arab Board of Medical Specializations.
At My Medicine Advisor, Dr. Hassan provides senior clinical oversight for internal medicine content, ensuring recommendations reflect real-world clinical experience and evidence-based best practices. His three decades of frontline experience inform practical, patient-centered health guidance.
Professional Affiliations: American College of Physicians (Fellow); Emirates Medical Association; Society of Hospital Medicine; European Society of Internal Medicine
Publications: 7 CME course curricula
Awards: Lifetime Achievement Award, Emirates Medical Association (2024); Excellence in Medical Education Award, Dubai Health Authority (2020)
Languages: Arabic; English; French
Knows about: Chronic disease management; hypertension and blood pressure control; diabetes mellitus complications; heart failure management; geriatric medicine and polypharmacy; hospital medicine and acute care; preventive internal medicine; medical education and mentorship
Induced Pluripotent Stem Cells: Can They Cure Disease?
Scientists can reprogram your own cells to fight Parkinson's, heart failure, and diabetes. Here's what the 2026 iPSC clinical trial data actually shows — and what it means for you.
Acupuncture: What 21,000 Patients Prove (2026)
A landmark study of 21,000+ patients finally proves acupuncture works. Expert 2026 guide covering benefits, costs, side effects & sessions by condition.
Radiation Therapy: Truth Every Patient Must Know
Everything radiation therapy patients need: 7 types explained, real side effects by body area, week-by-week experience, 2026 cost data & breakthrough FLASH technology.
Pancreatic Cancer Survival Rates in 2026: Why Outcomes Are Finally Improving & The 7 Warning Signs Most Doctors Miss
Pancreatic cancer survival has nearly doubled to 13% in 2026 — and new mRNA vaccines plus KRAS breakthroughs are pushing that number higher. See survival rates by stage, the 7 early warning signs doctors consistently overlook, and which new 2026 treatments are giving patients and families genuine reason for hope.
Liver Resection Results: Real Survival Rates (2026)
What are the real liver resection survival rates in 2026? This expert-reviewed guide breaks down outcomes by cancer type — HCC, CRLM, cholangiocarcinoma — with full recovery timelines.
Multiple Myeloma Survival in 2026: How New CAR-T Therapy Is Pushing Rates to 62% — And What It Means for Your Case
Multiple myeloma is no longer the death sentence it once was — 2026 CAR-T breakthroughs have pushed 5-year survival to 62.4%, the biggest jump in decades. See survival rates by stage, which new FDA-approved therapies are changing outcomes, and the exact questions to bring to your next oncology appointment.
Blood Cancer: Early Signs, Survival Rates & 2026 Breakthrough Cures
Blood cancer affects 1.24M people annually. Learn the 12 early warning signs, 2026 survival rates (up to 90% for some types), and breakthrough CAR T-cell therapies offering new hope for patients.
Bile Duct Cancer Survival Rates & 7 Warning Signs 2026
Discover 2026 bile duct cancer survival rates by stage, recognize 7 critical warning signs early, and explore breakthrough treatments including liver transplant protocols achieving 65% cure.
UCL Tear Grades 1–3 in 2026: Which Grades Need Surgery, Which Respond to PRP & What 92% Success Really Means
Not every UCL tear needs Tommy John surgery — and choosing the wrong treatment for your grade can cost you an entire season. This 2026 guide breaks down Grade 1, 2 and 3 tears by surgery necessity, PRP success rates, full $15,000–$35,000 cost breakdown, and recovery timelines ranging from 4 weeks to 18 months.